Ciudad Pedro, Manrique Oscar J, Bustos Samyd S, Vargas Maria I, Reynaga César, Agko Mouchammed, Huang Tony C T, Benites Eduardo Figueroa, Mayer Horacio F, Forte Antonio J
Department of Plastic, Reconstructive and Burn Surgery, Arzobispo Loayza National Hospital, Lima, Peru.
Department of Plastic and Reconstructive Surgery, Ciruesthetic Clinic, Lima, Peru.
Gland Surg. 2020 Apr;9(2):512-520. doi: 10.21037/gs.2020.01.14.
The combination of microvascular breast reconstruction (MBR) and vascularized lymph node transfer (VLNT) in a single-stage procedure is a surgical option for women who desire breast reconstruction and postmastectomy lymphedema surgery. In this study, we present a series of patients who underwent simultaneous lymphatic and MBR with the gastroepiploic VLNT (GE-VLNT) and the deep inferior epigastric perforator (DIEP) flap respectively.
Between 2018 and 2019, all consecutive patients diagnosed with lymphedema stage IIb-III International Society of Lymphology who opted to pursue simultaneous MBR with DIEP flap and GE-VLNT were included in this study. Patient demographics, comorbidities, prior radiation therapy, operative characteristics, surgical outcomes and complications were collected and analyzed.
Six patients underwent simultaneous unilateral MBR with DIEP flap and GE-VLNT. The mean age was 48±10.5 years and mean body mass index was 28.2±4.5 kg/m. The flap survival rate was 100%. One patient required re-exploration due to venous congestion of the lymph node flap but was successfully salvaged. There was no donor site morbidity at the donor or recipient site for the DIEP flap were seen. The mean circumference reduction rate was 30.0%±5.1% (P<0.001). One patient stage III underwent additional liposuction at 12 months postoperative to improve final results.
The combined use of DIEP flap and GE-VLNT flaps in a single-stage procedure is a safe and reliable surgical option for patients with postmastectomy lymphedema who desire and are suitable for autologous microvascular breast and lymphatic reconstruction.
在单阶段手术中,微血管乳房重建(MBR)与带血管蒂淋巴结转移(VLNT)相结合,是希望进行乳房重建和乳房切除术后淋巴水肿手术的女性的一种手术选择。在本研究中,我们介绍了一系列分别接受胃网膜带血管蒂淋巴结转移(GE-VLNT)和腹壁下深动脉穿支(DIEP)皮瓣同时进行淋巴和MBR手术的患者。
2018年至2019年期间,所有连续诊断为国际淋巴学会IIb-III期淋巴水肿且选择同时进行DIEP皮瓣MBR和GE-VLNT的患者均纳入本研究。收集并分析患者的人口统计学、合并症、既往放疗情况、手术特征、手术结果和并发症。
6例患者同时接受了单侧DIEP皮瓣MBR和GE-VLNT手术。平均年龄为48±10.5岁,平均体重指数为28.2±4.5kg/m。皮瓣成活率为100%。1例患者因淋巴结皮瓣静脉淤血需要再次手术探查,但成功挽救。DIEP皮瓣供区或受区均未出现供区并发症。平均周长缩小率为30.0%±5.1%(P<0.001)。1例III期患者术后12个月进行了额外的抽脂手术以改善最终效果。
对于希望并适合自体微血管乳房和淋巴重建的乳房切除术后淋巴水肿患者,在单阶段手术中联合使用DIEP皮瓣和GE-VLNT皮瓣是一种安全可靠的手术选择。